Selected as TIPS (Tech Incubator Program for startup)
(w/Bluepoint Partners)

Selected as a member company of Shinhan Square Bridge
Incheon Accelerating
(Shinhan Financial Group Hope Foundation)

Selected as a member company for the 2nd term of KOTRA
IKMP (Invest KOREA Market Place) (KOTRA)

Selected as a participating company for Korea-Europe
Biomedical Partners (KOTRA, Korea Pharmaceutical and
Biotechnology Association)

Selected for investment attraction brokerage support
business in 2022 (Korea Health Industry Development
Institute, Genaxis)

Selected as a start-up intellectual property voucher
business in 2022 (Korea Intellectual Property Service Center)

Selected as a business to support bio research data verification
in 2022 (Commercialization Promotion Agency for R&D Outcomes)

Selected as First Penguin start-up company
(Korea Credit Guarantee Fund)

Selected as a network R&DB planning support project in 2022
(Ministry of SMEs and Startups)

Establishment of Corporate Affilated Research Institute
(Korea Industrial Technology Association)

Conducted research on the formulation of
biopharmaceutical eye drops (H Bio)

Selected as the 2021 pharmaceutical patent response
strategy consulting support business
(Korea Pharmaceutical and Bio-Pharma Manufacturers Association)

E&Venture Partners, Blue Point Partners,
Daewoong Pharmaceutical Investment attraction

Diabetes drug formulation research commissioned research (D-Bio)

Selected as a bio research data verification support project in 2021
(Commercialization Promotion Agency for R&D Outcomes)

Bio-industrial technology development,
customized diagnostic treatment product project selection
(Ministry of Trade, Industry and Energy)

Signed an MOU with D Pharmaceutical to produce
its own depot drug clinical trial drug

Established TionLabTherapeutics Co., Ltd.